Identification of genes causing photoreceptor degenerations leading to blindness

Current Opinion in Neurobiology

Volumn 7, Issue 5, 1997, Pages 666-673

  Farber, Debora B ^a   Danciger, Michael ^b  

^a JULES STEIN EYE INSTITUTE   (United States)

^b LOYOLA MARYMOUNT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERIPHERIN;

BLINDNESS; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HUMAN; MOLECULAR CLONING; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA DISEASE; RETINA MACULA DEGENERATION; REVIEW; X CHROMOSOME LINKAGE;

EID: 0030813163     PISSN: 09594388     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-4388(97)80087-6     Document Type: Article

References (94)

1. Heckenlively JR: The diagnosis and classification of retinitis pigmentosa. In Retinitis Pigmentosa. Philadelphia: JB Lippincott Company; 1988:21-23.
2. Pagon RA: Retinitis pigmentosa. Surv Ophthalmol 1988, 33:137-177.
3. Greenberg J, Bartmann L, Ramesar R, Beighton P: Retinitis pigmentosa in Southern Africa. Clin Genet 1993, 44:232-235.
4. Nathans J, Hogness DS: Isolation and nucleotide sequence of the gene encoding human rhodopsin. Proc Natl Acad Sci USA 1984, 81:4851-4855.
5. Sparkes RS, Klisak I, Kaufman D, Mohandas T, Tobin AJ, McGinnis JF: Assignment of the rhodopsin gene to human chromosome three, region 3q21 -3q24 by in situ hybridization studies. Curr Eye Res 1986, 5:797-798.
6. Washburn T, O'Tousa JE: Molecular defects in Drosophila rhodopsin mutants. J Biol Chem 1989, 264:15464-15466.
7. McWilliam P, Farrar GJ, Kenna P, Bradley DG, Humphries MM, Sharp EM, McConnell DJ, Lawler M, Sheils D, Ryan C et al.: Autosomal dominant retinitis pigmentosa (ADRP): localization of an ADRP gene to the long arm of chromosome 3. Genomics 1989. 5:619-622.
8. Dryja TP, McGee TL, Reichel E, Hahn LB, Cowley GS, Yandell DW, Sandberg MA, Berson EL: A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature 1990. 343:364-366.
9. Gal A, Apfelstedt-Sylla E, Janecke AR, Zrenner E: Rhodopsin mutations in inherited retinal dystrophies and dysfunctions. Prog Ret Eye Res 1997, 16:51-79. This comprehensive review summarizes all the work related to rhodopsin mutations in retinal dystrophies. It includes a description of the rhodopsin protein and its role in phototransduction and a listing of each of the mutations responsible for adRP, arRP and CSNB. There is also an extensive discussion of possible mechanisms for how the various mutations in rhodopsin bring about different symptoms predicted by changes in its secondary and tertiary structure.
10. Haim M, Grundmann K, Gal A, Rosenberg T: Novel rhodopsin mutation (M216R) in a Danish family with autosomal dominant retinitis pigmentosa. Ophthalmic Genet 1996, 17:193-197.
11. Kumaramanickavel G, Maw M, Denton MJ, John S, Srikumari CR, Orth U, Oehlmann R, Gal A: Missense rhodopsin mutation in a family with recessive RP [letter]. Nat Genet 1994, 8:10-11.
12. Rosenfeld PJ, Cowley GS, McGee TL, Sandberg MA, Berson EL, Dryja TP: A null mutation in the rhodopsin gene causes rod photoreceptor dysfunction and autosomal recessive retinitis pigmentosa. Nat Genet 1992, 1:209-213.
13. Sieving PA, Richards JE, Naarendorp F, Bingham EL, Scott K, Alpern M: Dark-light: model for nightblindness from the human rhodopsin Gly-90→Asp mutation. Proc Natl Acad Sci USA 1995, 92:880-884.
14. Dryja TP, Berson EL, Rao VR, Oprian DD: Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat Genet 1993, 4:280-283.
15. Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB: Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature 1990, 347:677-680.
16. Bowes C, Li T, Frankel WN, Danciger M, Coffin JM, Applebury ML, Farber DB: Localization of a retroviral element within the rd gene coding for the beta subunit of cGMP phosphodiesterase. Proc Natl Acad Sci USA 1993, 90:2955-2959.
17. Pittler SJ, Baehr W: Identification of a nonsense mutation in the rod photoreceptor cGMP phosphodiesterase beta-subunit gene of the rd mouse. Proc Natl Acad Sci USA 1991, 88:8322-8326.
18. Farber DB, Danciger JS, Aguirre G: The beta subunit of cyclic GMP phosphodiesterase mRNA is deficient in canine rod-cone dysplasia 1. Neuron 1992, 9:349-356.
19. Suber ML, Pittler SJ, Qin N, Wright GC, Holcombe V, Lee RH, Craft CM, Lolley RN, Baehr W, Hurwitz RL: Irish setter dogs affected with rod/cone dysplasia contain a nonsense mutation in the rod cGMP phosphodiesterase beta-subunit gene. Proc Natl Acad Sci USA 1993, 90:3968-3972.
20. McLaughlin ME, Ehrhart TL, Berson EL, Dryja TP: Mutation spectrum of the gene encoding the beta subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa. Proc Natl Acad Sci USA 1995, 92:3249-3253.
21. Danciger M, Heilbron V, Gao YQ, Zhao D-Y, Jacobson SG, Farber DB: A homozygous PDE6B mutation in a family with autosomal recessive retinitis pigmentosa. Mol Vis 1996, 2:10. [URL: http://www.emory.edu/molvis/v2/danciger]
22. Valverde D, Baiget M, Seminago R, del Rio E, Garcia-Sandoval B, del Rio T, Bayes M, Balcells S, Martinez A, Grinberg D et al.: Identification of a novel R552O mutation in exon 13 of the beta-subunit of rod phosphodiesterase gene in a Spanish family with autosomal recessive retinitis pigmentosa. Hum Mutat 1996, 8:393-394.
23. Bayes M, Martinez-Mir A, Valverde D, del Rio E, Vilageliu L, Grinberg D, Balcells S, Ayuso C, Baiget M, Gonzalez-Duarte R: Autosomal recessive retinitis pigmentosa in Spain: evaluation of four genes and two loci involved in the disease. Clin Genet 1996, 50:380-387.
24. Gao YQ, Danciger M, Zhao DY, Blaney J, Piriev NI, Shih J, Jacobson SG, Heckenlively JH, Farber DB: Screening of the PDE6B gene in patients with autosomal dominant retinitis pigmentosa. Exp Eye Res 1996, 62:149-154.
25. Gal A, Orth U, Baehr W, Schwinger E, Rosenberg T: Heterozygous missense mutation in the rod cGMP phosphodiesterase beta-subunit gene in autosomal dominant stationary night blindness [published erratum appears in Nat Genet 1994, 7:551]. Nat Genet 1994, 7:64-68.
26. Huang SH, Pittler SJ, Huang X, Oliveira L, Berson EL, Dryja TP: Autosomal recessive retinitis pigmentosa caused by mutations in the alpha subunit of rod cGMP phosphodiesterase. Nat Genet 1995, 11:468-471.
27. Dryja TP, Finn JT, Peng YW, McGee TL, Berson EL, Yau KW: Mutations in the gene encoding the alpha subunit of the rod cGMP-gated channel in autosomal recessive retinitis pigmentosa. Proc Natl Acad Sci USA 1995, 92:10177-10181.
28. Hahn LB, Berson EL, Dryja TP: Evaluation of the gene encoding the gamma subunit of rod phosphodiesterase in retinitis pigmentosa. Invest Ophthalmol Vis Sci 1994, 35:1077-1082.
29. Ara-Iwata F, Jacobson SG, Gass JD, Hotta Y, Fujiki K, Hayakawa M, Inana G: Analysis of phosducin as a candidate gene for retinopathies. Ophthalmic Genet 1996, 17:3-14.
30. Bayes M, Valverde D, Balcells S, Grinberg D, Vilageliu L, Benitez J, Ayuso C, Beneyto M, Baiget M, Gonzalez-Duarte R: Evidence against involvement of recoverin in autosomal recessive retinitis pigmentosa in 42 Spanish families. Human Genet 1995, 96:89-94.
31. Parminder AH, Murakami A, Inana G, Berson EL, Dryja TP: Evaluation of the human gene encoding recoverin in patients with retinitis pigmentosa or an allied disease. Invest Ophthalmol Vis Sci 1997, 38:704-709.
32. Dryja TP, Hahn LB, Reboul T, Arnaud B: Missense mutation in the gene encoding the alpha subunit of rod transducin in the Nougaret form of congenital stationary night blindness. Nat Genet 1996, 13:358-360. Mutations in the α subunit of the rod transducin gene were detected in the Nougaret family only after the SSCPE screening of at least 10 other candidate genes. The paper is interesting because of the history of the Nougaret family, the pedigree, and the identification of the possible index case in Jean Nougaret, a butcher who lived in southern France from 1637 to 1719.
33. Wilden U, Hall SW, Kuhn H: Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc Natl Acad Sci USA 1986, 83:1174-1178.
34. Carr RE, Ripps H, Siegel IM, Weale RA: Rhodopsin kinetics and rod adaptation in Oguchi's disease. Invest Ophthalmol Vis Sci 1967, 6:426-436.
35. Maw MA, John S, Jablonka S, Muller B, Kumaramanickavel G, Oehlmann R, Denton MJ, Gal A: Oguchi disease: suggestion of linkage to markers on chromosome 2q. J Med Genet 1995, 32:396-398.
36. Ngo JT, Klisak I, Sparkes RS, Mohandas T, Yamaki K, Shinohara T, Bateman JB: Assignment of the S-antigen gene (SAG) to human chromosome 2q24-q37. Genomics 1990, 7:84-87.
37. Valverde D, Bayes M, Martinez I, Grinberg D, Vilageliu L, Balcells S, Gonzalez-Duarte R, Baiget M: Genetic fine localization of the arrestin (S-antigen) gene 4 cM distal from D2S172. Hum Genet 1994, 94:193-194.
38. Fuchs S, Nakazawa M, Maw M, Tamai M, Oguchi Y, Gal A: A homozygous 1 -base pair deletion in the arrestin gene is a frequent cause of Oguchi disease in Japanese. Nat Genet 1995, 10:360-362.
39. Yamamoto S, Sippel KC, Berson EL, Dryja TP: Defects in the rhodopsin kinase gene in the Oguchi form of stationary night blindness. Nat Genet 1997, 15:175-178. This is an example of the selection of a candidate gene for study based solely on the specific physiological function of the protein that it encodes. The symptom of Oguchi disease is the prolonged delay of recovery of the rods from light exposure. The arrestin and rhodopsin kinase genes are both involved in speeding up the recovery of bleached rhodopsin. Therefore, they were both prime candidates for mutation in Oguchi disease. Mutations in rhodopsin kinase associated with Oguchi disease are described. Mutations in the arrestin gene were described in a previous paper [38].
40. Camuzat A, Rozet JM, Dollfus H, Gerber S, Perrault I, Weissenbach J, Munnich A, Kaplan J: Evidence of genetic heterogeneity of Leber's congenital amaurosis (LCA) and mapping of LCA1 to chromosome 17p13. Hum Genet 1996, 97:798-801.
41. Perrault I, Rozet JM, Calvas P, Gerber S, Camuzat A, Dollfus H, Chatelin S, Souied E, Ghazi I, Leowski C et al: Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosis. Nat Genet 1996, 14:461-464. Previous linkage analyses localized the gene responsible for Leber's congenital amaurosis (LCA) to a 1 cM region of chromosome 17p13, and positional cloning work provided a set of 12 YAC clones in this region. There happened to be five candidate genes that had previously been mapped to chromosome 17p13 and each of these was tested by hybridization for its presence in the set of YACs. Four of the genes were not present, but the fifth, retGC (retinal guanylate cyclase), was. The exon/intron boundaries of the gene were then determined on the basis of the work done on the mouse gene, and the exons were screened by SSCPE for mutations that were found in at least four families. In addition, the possible effect of retGC mutations in the pathology of LCA is proposed, and the point is made that there is at least one other LCA locus and one other guanylate cyclase gene.
42. Oliveira L, Miniou P, Viegas-Pequignot E, Rozet JM, Dollfus H, Pittler SJ: Human retinal guanylate cyclase (GUC2D) maps to chromosome 17p13.1. Genomics 1994, 22:478-481.
43. Travis GH, Brennan MB, Danielson PE, Kozak CA, Sutcliffe JG: Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature 1989, 338:70-73.
44. Connell G, Bascom R, Molday L, Reid D, McInnes RR, Molday RS: Photoreceptor peripherin is the normal product of the gene responsible for retinal degeneration in the rds mouse. Proc Natl Acad Sci USA 1991, 88:723-726.
45. Travis GH, Christerson L, Danielson PE, Klisak I, Sparkes RS, Hahn LB, Dryja TP, Sutcliffe JG: The human retinal degeneration slow (RDS) gene: chromosome assignment and structure of the mRNA. Genomics 1991, 10:733-739.
46. Keen TJ, Inglehearn CF: Mutations and polymorphisms in the human peripherin-RDS gene and their involvement in inherited retinal degeneration. Hum Mutat 1996, 8:297-303. This report provides a comprehensive history of the discovery of the mutant Rds murine gene, and a description of the protein it encodes. The mutation spectrum is presented along with an attempt to correlate phenotype with the position of the mutation in the protein in the extremely heterogeneous group of dystrophies caused by peripherin/RDS mutations. This task is helped by an excellent organization of peripherin/RDS phenotypes into four broad categories: RP, severe macular degenerations, pattern-type dystrophies and digenic RP (the first three categories are autosomal dominant). However, for this particular gene, the phenotype/genotype correlations are still quite complex and not yet clearly delineated.
47. Kajiwara K, Hahn LB, Mukai S, Travis GH, Berson EL, Dryja TP: Mutations in the human retinal degeneration slow gene in autosomal dominant retinitis pigmentosa. Nature 1991, 354:480-483.
48. Arikawa K, Molday LL, Molday RS, Williams DS: Localization of peripherin/rds in the disk membranes of cone and rod photoreceptors: relationship to disk membrane morphogenesis and retinal degeneration. J Cell Biol 1992, 116:659-667.
49. Wells J, Wroblewski J, Keen J, Inglehearn C, Jubb C, Eckstein A, Jay M, Arden G, Bhattacharya S, Fitzke F et al.: Mutations in the human retinal degeneration slow (RDS) gene can cause either retinitis pigmentosa or macular dystrophy. Nat Genet 1993, 3:213-218.
50. Nichols BE, Sheffield VC, Vandenburgh K, Drack AV, Kimura AE, Stone EM: Butterfly-shaped pigment dystrophy of the fovea caused by a point mutation in codon 167 of the RDS gene. Nat Genet 1993, 3:202-207.
51. Lam BL, Vandenburgh K, Sheffield VC, Stone EM: Retinitis pigmentosa associated with a dominant mutation in codon 46 of the peripherin/RDS gene (arginine-46-stop). Am J Ophthalmol 1995, 119:65-71.
52. Nakazawa M, Naoi N, Wada Y, Nakazaki S, Maruiwa F, Sawada A, Tamai M: Autosomal dominant cone-rod dystrophy associated with a Val200Glu mutation of the peripherin/RDS gene. Retina 1996, 16:405-410.
53. Fossarello M, Bertini C, Galantuomo MS, Cao A, Serra A, Pirastu M: Deletion in the peripherin/RDS gene in two unrelated Sardinian families with autosomal dominant butterfly-shaped macular dystrophy. Arch Ophthalmol 1996, 114:448-456.
54. Weleber RG, Carr RE, Murphey WH, Sheffield VC, Stone EM: Phenotypic variation including retinitis pigmentosa, pattern dystrophy, and fundus flavimaculatus in a single family with a deletion of codon 153 or 154 of the peripherin/RDS gene. Arch Ophthalmol 1993, 111:1531-1542.
55. Hoyng CB, Heutink P, Testers L, Pinckers A, Deutman AF, Oostra BA: Autosomal dominant central areolar choroidal dystrophy caused by a mutation in codon 142 in the peripherin/RDS gene. Am J Ophthalmol 1996, 121:623-629. DNA sequencing was performed on the exons of the peripherin/RDS gene in members of 7 families with autosomal dominant central areolar choroidal dystrophy and on those of 4 sporadic or simplex patients. An Arg142→Trp mutation was found only in affected members of all 7 families. However, no mutations were found in the exons of the 4 simplex cases. This paper is interesting for several reasons: first, the selection of the peripherin/RDS candidate gene based on its association with other macular dystrophies; second, yet another phenotype for peripherin/RDS mutations; third, the suggestion of a founder, as all 7, apparently unrelated, families carried the same mutation; finally, the implication of peripherin/RDS as one possible candidate for age-related macular degeneration.
56. Reig C, Serra A, Gean E, Vidal M, Arumi J, De la Calzada MD, Antich J, Carballo M: A point mutation in the RDS-peripherin gene in a Spanish family with central areolar choroidal dystrophy. Ophthalmic Genet 1995, 16:39-44.
57. Lotery AJ, Ennis KT, Silvestri G, Nicholl S, McGibbon D, Collins AD, Hughes AE: Localisation of a gene for central areolar choroidal dystrophy to chromosome 17p. Hum Genet 1996, 5:705-708.
58. Kajiwara K, Berson EL, Dryja TP: Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 1994, 264:1604-1608.
59. Goldberg AF, Molday RS: Defective subunit assembly underlies a digenic form of retinitis pigmentosa linked to mutations in peripherin/rds and rom-1. Proc Natl Acad Sci USA 1996, 93:13726-13730. The issue of why the heterozygous Leu185→Pro mutation in peripherin/RDS combined with a heterozygous null mutation in ROM1 causes photoreceptor degeneration while alone neither causes disease is tackled in this paper. The sedimentation velocity evidence presented suggests that when peripherin/RDS is normal, it can form a native-like homo-oligomeric membrane complex, even if a mutant ROM1 is present. However, in the case of the mutation, peripherin/RDS can form a functional hetero-oligomeric complex with normal ROM1, but not with itself nor with mutant ROM1. Extrapolating to in vivo digenic retinal disease, the mutant peripherin/RDS is dependent upon normal ROM1 to produce a functional disc membrane complex, but when the heterozygous ROM1 null is also present, an insufficient amount of normal protein is available to maintain disc integrity.
60. Bascom RA, Liu L, Heckenlively JR, Stone EM, Mclnnes RR: Mutation analysis of the ROM1 gene in retinitis pigmentosa. Hum Mol Genet 1995, 4:1895-1902.
61. Bascom RA, Garcia-Heras J, Hsieh CL, Gerhard DS, Jones C, Francke U, Willard HF, Ledbetter DH, Mclnnes RR: Localization of the photoreceptor gene ROM1 to human chromosome 11 and mouse chromosome 19: sublocalization to human 11q13 between PGA and PYGM. Am J Hum Genet 1992, 51:1028-1035.
62. Forsman K, Graff C, Nordstrom S, Johansson K, Westermark E, Lundgren E, Gustavson KH, Wadelius C, Holmgren G: The gene for Best's macular dystrophy is located at 11 q13 in a Swedish family. Clin Genet 1992, 42:156-159.
63. Nichols BE, Bascom R, Litt M, Mclnnes R, Sheffield VC, Stone EM: Refining the locus for Best vitelliform macular dystrophy and mutation analysis of the candidate gene ROM1. Am J Hum Genet 1994, 54:95-103.
64. Hou YC, Richards JE, Bingham EL, Pawar H, Scott K, Segal M, Lunetta KL, Boehnke M, Sieving PA: Linkage study of Best's vitelliform macular dystrophy (VMD2) in a large North American family. Hum Hered 1996, 46:211-220.
65. Kaplan J, Gerber S, Larget-Piet D, Rozet JM, Dollfus H, Dufier JL, Odent S, Postel-Vinay A, Janin N, Briard ML et al.: A gene for Stargardt's disease (fundus flavimaculatus) maps to the short arm of chromosome 1 [published erratum appears in Nat Genet 1994, 6:214]. Nat Genet 1993, 5:308-311.
66. Hoyng CB, Poppelaars F, van de Pol TJ, Kremer H, Pinckers AJ, Deutman AF, Cremers FP: Genetic fine mapping of the gene for recessive Stargardt disease. Hum Genet 1996, 98:500-504.
67. Weber BH, Sander S,.Kopp C, Walker D, Eckstein A, Wissinger B, Zrenner E, Grimm T: Analysis of 21 Stargardt's disease families confirms a major locus on chromosome 1p with evidence for non-allelic heterogeneity in a minority of cases. Br J Ophthamol 1996, 80:745-749.
68. Gerber S, Rozet JM, Bonneau D, Souied E, Weissenbach J, Frezal J, Munnich A, Kaplan J: Exclusion of the cone-specific alpha-subunit of the transducin gene in Stargardt's disease. Hum Genet 1995, 95:382-384.
69. Rozet JM, Gerber S, Perrault I, Camuzat A, Calvas P, Viegas-Pequignot E, Molina-Gomes D, Le Paslier D, Chumakov I, Munnich A et al.: Structure and physical mapping of DR1, a TATA-binding protein-associated phosphoprotein gene, to chromosome 1p22.1 and its exclusion in Stargardt disease (STGD). Genomics 1996, 36:554-556.
70. Illing M, Molday LL, Molday RS: The 220-kDa rim protein of retinal rod outer segments is a member of the ABC transporter superfamily. J Biol Chem 1997, 272:10303-10310.
71. Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, Gerrard B, Baird L, Stauffer D, Peiffer A et al.: A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 1997, 15:236-246. This paper presents the interesting story of how the study of a group of genes (21 in all), the ATP-binding transporters, led to the identification of a candidate for Stargardt's disease based on its chromosomal locus. A partial screening of the exons of the gene in a group of patients revealed mutations that were associated with disease in several families. In addition, in situ hybridization showed that the message corresponding to the gene is expressed in rods but not cones. This provides a bit of a mystery as Stargardt's is a disease that occurs primarily in the macula. Hypotheses are developed to try to explain why a rod-specific gene does not cause more disease in the periphery of the retina where the relative proportion of rods to cones is much higher than in the macula. The work also poses the possibility that other retinal dystrophies may be caused by other members of this family of ATP-binding transporter genes.
72. Sorsby A, Mason MEJ, Gardener N: A fundus dystrophy with unusual features. Br J Ophthalmol 1949, 33:67-97.
73. Weber BH, Vogt G, Wolz W, Ives EJ, Ewing CC: Sorsby's fundus dystrophy is genetically linked to chromosome 22q13-qter. Nat Gene 1994, 7:158-161.
74. Apte SS, Mattei MG, Olsen BR: Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22. Genomics 1994, 19:86-90.
75. Weber BH, Vogt G, Pruett RC, Stohr H, Felbor U: Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy. Nat Genet 1994, 8:352-356.
76. Wijesuriya SD, Evans K, Jay MR, Davison C, Weber BHF, Bird AC, Bhattacharya SS, Gregory CY: Sorsby's fundus dystrophy in the British Isles: demonstration of a striking founder effect by microsatellite-generated haplotypes. Genome Res 1996, 6:92-101. The discovery of the same TIMP3 mutation (Ser181→Cys) being responsible for Sorsby's fundus dystrophy (SFD) in 15 apparently unrelated families from different parts of the British Isles led these authors to consider a common founder for this mutation. Haplotype analysis revealed an allele of the marker D22S280 to be present in all affected individuals, while its frequency in control populations was only 11%. Further studies defined a common 3cM locus in 68% of all chromosomes studied. The frequency moved to 95% if the locus was expanded to 7 cM; perhaps this 7 cM region was the haplotype of the founder. This work suggests a common founder for at least the majority of SFD in the British Isles.
77. Bird AC: X-linked retinitis pigmentosa. Br J Ophthalmol 1975, 59:177-199.
78. Fishman GA, Farber MD, Derlacki DJ: X-linked retinitis pigmentosa. Profile of clinical findings. Arch Ophthalmol 1988, 106:369-375.
79. Meindl A, Dry K, Herrmann K, Manson F, Ciccodicola A, Edgar A, Carvalho MR, Achatz H, Hellebrand H, Lennon A et al.: A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet 1996, 13:35-42. The entire history from the first identification of the locus of RP3 at Xp21 to the finding of mutations in the RPGR gene is presented in this paper. This includes the refinement of the locus based on various deletions, one of which led the work off in the wrong direction for some time. It also includes the identification of a good candidate gene in the locus, ETX1. This gene did not have mutations associated with RP3 XLRP, however. There is a description of this novel RPGR gene and extensive discussion of its possible function and relationship with homologous genes. The mutations found in 7 families are presented, and the authors also speculate about the fact that mutations were not detected in 67 additional families studied. They suggest that mutations were simply missed due to technical limitations, that mutations exist in regions not tested (such as introns or control regions), and/or there is another gene at the locus.
80. Dry KL, Aldred MA, Edgar AJ, Brown J, Manson FD, Ho MF, Prosser J, Hardwick LJ, Lennon AA, Thomson K et al.: Identification of a novel gene, ETX1 from Xp21.1, a candidate gene for X-linked retinitis pigmentosa (RP3). Hum Mol Genet 1995, 4:2347-2353.
81. Roepman R, van Duijnhoven G, Rosenberg T, Pinckers AJ, Bleeker-Wagemakers LM, Bergen AA, Post J, Beck A, Reinhardt R, Ropers HH et al.: Positional cloning of the gene for X-linked retinitis pigmentosa 3: homology with the guanine-nucleotide-exchange factor RCC1. Hum Mol Genet 1996, 5:1035-1041.
82. Cremers FP, van de Pol DJ, van Kerkhoff LP, Wieringa B, Ropers HH: Cloning of a gene that is rearranged in patients with choroideraemia. Nature 1990, 347:674-677.
83. Merry DE, Janne PA, Landers JE, Lewis RA, Nussbaum RL: Isolation of a candidate gene for choroideremia. Proc Natl Acad Sci USA 1992, 89:2135-2139.
84. Van Bokhoven H, van den Hurk JA, Bogerd L, Philippe C, Gilgenkrantz S, de Jong P, Ropers HH, Cremers FP: Cloning and characterization of the human choroideremia gene. Hum Mol Genet 1994, 3:1041-1046.
85. Andres DA, Seabra MC, Brown MS, Armstrong SA, Smeland TE, Cremers FP, Goldstein JL: cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein. Cell 1993, 73:1091-1099.
86. Van den Hurk JA, Schwartz M, van Bokhoven H, van de Pol TJ, Bogerd L, Pinckers AJ, Bleeker-Wagemakers EM, Pawlowitzki IH, Ruther K, Ropers HH et al.: Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene. Hum Mutat 1997, 9:110-117. This paper is an update on choroideremia mutations. The authors provide a comprehensive history of the mapping of the locus, the positional cloning of the Rab escort protein 1 gene (REP1) and the discovery of its function. The mutations that have so far been found in this gene are catalogued; about one-quarter of European patients with choroideremia have large deletions, but these have not been found in North American patients (at least not yet). The remaining 20 mutations are either null mutations or splice mutations or small deletions or insertions causing frameshifts resulting in premature terminations. The absence of missense mutations associated with this disease suggests that only when the gene product is absent does choroideremia occur. The authors speculate that missense REP1 mutations may cause another form of retinal disease. In Europe, mutations in REP1 have now been identified in two-thirds of all patients with choroideremia.
87. Smith RJ, Berlin CI, Hejtmancik JF, Keats BJ, Kimberling WJ, Lewis RA, Moller CG, Pelias MZ, Tranebjaerg L: Clinical diagnosis of the Usher syndromes. Usher Syndrome Consortium. Am J Med Genet 1994, 50:32-38.
88. Guilford P, Ayadi H, Blanchard S, Chaib H, Le Paslier D, Weissenbach J, Drira M, Petit C: A human gene responsible for neurosensory, non-syndromic recessive deafness is a candidate homologue of the mouse sh-1 gene. Hum Mol Genet 1994, 3:989-993.
89. Gibson F, Walsh J, Mburu P, Varela A, Brown KA, Antonio M, Beisel KW, Steel KP, Brown SD: A type VII myosin encoded by the mouse deafness gene shaker-1. Nature 1995, 374:62-64.
90. Weil D, Blanchard S, Kaplan J, Guilford P, Gibson F, Walsh J, Mburu P, Varela A, Levilliers J, Weston MD et al.: Defective myosin VIIA gene responsible for Usher syndrome type 1B. Nature 1995, 374:60-61.
91. Levy G, Levi-Acobas F, Blanchard S, Gerber S, Larget-Piet D, Chenal V, Liu XZ, Newton V, Steel KP, Brown SD et al.: Myosin VIIA gene: heterogeneity of the mutations responsible for Usher syndrome type 1B. Hum Mol Genet 1997, 6:111-116.
92. El-Amraoui A, Sahly I, Picaud S, Sahel J, Abitbol M, Petit C: Human Usher 1B/mouse shaker-1: the retinal phenotype discrepancy explained by the presence/absence of myosin VIIA in the photoreceptor cells. Hum Mol Genet 1996, 5:1171-1178.
93. Al-Maghtheh M, Vithana E, Tarttelin E, Jay M, Evans K, Moore T, Bhattacharya S, Inglehearn CF: Evidence for a major retinitis pigmentosa locus on 19q13.4 (RP11) and association with a unique bimodal expressivity phenotype. Am J Hum Genet 1996, 59:864-871. This is a report of three families segregating a 19q34 locus that was previously identified in two other families. In all five of the families, there is bimodal expressivity of disease: it is either severe or absent (i.e. there are obligate carriers of this adRP gene that do not have any disease). This argues strongly for a single second gene that influences whether or not disease is expressed, a background gene.
94. Farber DB: From mice to men: the cyclic GMP phosphodiesterase gene in vision and disease. Invest Ophthalmol Vis Sci 1995, 36:263-275.